Close Menu


LaunchCyte, a Pittsburgh-based bioinformatics incubator, has decided to pour its financial rocket fuel into a bead-based molecular barcoding method, developed at Indiana University, that it hopes will blast off into the commercial sphere.

Applied Precision and MolecularWare have entered into a reseller relationship. Under the agreement, MolecularWare s DigitalGenome software will be integrated into Applied Precision s arrayWoRxe microarray biochip readers and will be marketed under the name softWoRxTracker.

Agilent Technologies has signed a technology access agreement to supply DNA microarrays and a microarray scanner to institutes of the Royal Netherlands Academy of Science.

With a flood of federal dollars now flowing into high-tech defense efforts, several genomics companies have reported winning defense-related contracts to develop advanced biochips.

Genomic Solutions said last week that its third-quarter revenue would be lower than originally expected, blaming shrinking orders and economic uncertainty in the wake of the attacks on the World Trade Center and the Pentagon on Sept. 11.

Microfluidics leader Caliper Technologies has spun out a $25 million startup Amphora, which will use Caliper s LabChip technology to develop a chemical genomics database for pharmaceutical drug discovery, the company said.

PATENT WATCH: Sep 28, 2001


The University of Texas System, Motorola Life Sciences

Peter Wolstenholme has been appointed managing director of Stratagene Europe. Prior to joining Stratagene, Wolstenholme was vice president of sales and marketing at MWG Biotech.

Clondiag chip technologies of Jena, Germany, has released IconoClust, an array imaging software that allows automated analysis of both individual array images and groups of array images.

PhD in biochemistry from Cambridge University.
Postdoctoral fellowship at Stanford University. Research interests focus on applying flow cytometry and cell flow techniques to work in plant physiology.


The Wall Street Journal reports on the struggle to meet the demand for rapid COVID-19 testing.

The Newsroom reports New Zealand is using genomics to trace the origins of its new coronavirus outbreak.

In Nature this week: researchers in Canada sequence the genome of the black mustard plant Brassica nigra, and more.

According to Bloomberg, Moderna has a $1.5 billion vaccine deal with the US to provide 100 million doses.